NANOMIST - Nanoparticles at the Medicine Interface with Science and Technology
Project Information
Principal Investigator | Roy M. Harrison |
Institution | University of Birmingham |
Project URL | View |
Relevance to Implications | High |
Class of Nanomaterial | Generic |
Impact Sector | Human Health |
Broad Research Categories |
Exposure Hazard Safety Characterization Risk Assessment Risk Management |
NNI identifier |
Funding Information
Country | UK |
Anticipated Total Funding | $123,803.00 |
Annual Funding | $61,901.50 |
Funding Source | EPSRC |
Funding Mechanism | Extramural |
Funding Sector | Government |
Start Year | 2005 |
Anticipated End Year | 2007 |
Abstract/Summary
Nanoparticles at the Medicine Interface with Science and Technology (NANOMIST) brings together those involved in the production, characterisation and applications of nanoparticles with the health effects community. It aims to facilitate the creation of multi-disciplinary research and development in the area of nanoparticles to improve the information, instrumentation and methods available to those interested in bio-responses to ambient particles. As the development of nanoparticles grows, so too is there an increase in the extent and range of nanoparticle exposure within the work force. NANOMIST hopes to develop a greater knowledge by the health effects community of types of nanoparticles being used or developed for industrial applications, as well as the possibility of harnessing the skills of the physical science/engineering community to manufacture custom-built particles which could be used to elucidate mechanisms of adverse effect. NANOMIST enables the dissemination of knowledge through network meetings, specialized workshops and via the internet.
Publications and Presentations to date: None Additional Outcomes: NANOMIST achieves its outcomes through the establishment of conferences and workshops. To date NANOMIST has held one conference designed to bring together the various disciplines and communities involved in nanomaterial research, manufacture, exploitation and regulation, with a view ultimately to developing collaborative research aimed at a better understanding of the health risks posed by nanoparticles. NANOMIST is hosting two further one day workshops on the Physical and Chemical Properties of nanoparticles’ and defining the toxicology of nanoparticles for humans.’